Smith HL - Search Results

1

DNA damage checkpoint kinases in cancer.

Smith HL, Southgate H, Tweddle DA, Curtin NJ. Smith HL, et al. Expert Rev Mol Med. 2020 Jun 8;22:e2. doi: 10.1017/erm.2020.3. Expert Rev Mol Med. 2020. PMID: 32508294 Review.

2

Exploring the Synergy between PARP and CHK1 Inhibition in Matched BRCA2 Mutant and Corrected Cells.

Smith HL, Prendergast L, Curtin NJ. Smith HL, et al. Cancers (Basel). 2020 Apr 4;12(4):878. doi: 10.3390/cancers12040878. Cancers (Basel). 2020. PMID: 32260355 Free PMC article.

3

Differences in Durability of PARP Inhibition by Clinically Approved PARP Inhibitors: Implications for Combinations and Scheduling.

Smith HL, Willmore E, Mukhopadhyay A, Drew Y, Curtin NJ. Smith HL, et al. Cancers (Basel). 2022 Nov 12;14(22):5559. doi: 10.3390/cancers14225559. Cancers (Basel). 2022. PMID: 36428653 Free PMC article.

4

ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors.

Smith HL, Willmore E, Prendergast L, Curtin NJ. Smith HL, et al. Br J Cancer. 2024 Sep;131(5):905-917. doi: 10.1038/s41416-024-02745-0. Epub 2024 Jul 4. Br J Cancer. 2024. PMID: 38965423 Free PMC article.

5

MicroRNA levels quantified in whole blood varies from PBMCs.

Atarod S, Smith H, Dickinson A, Wang XN. Atarod S, et al. F1000Res. 2014 Aug 5;3:183. doi: 10.12688/f1000research.4884.4. eCollection 2014. F1000Res. 2014. PMID: 26500764 Free PMC article.

6

Developing a 3D bone model of osteosarcoma to investigate cancer mechanisms and evaluate treatments.

Smith HL, Beers SA, Kanczler JM, Gray JC. Smith HL, et al. FASEB J. 2024 Dec 13;38(24):e70274. doi: 10.1096/fj.202402011R. FASEB J. 2024. PMID: 39724514 Free PMC article.

7

Out of (the) bag-encoding categorical predictors impacts out-of-bag samples.

Smith HL, Biggs PJ, French NP, Smith ANH, Marshall JC. Smith HL, et al. PeerJ Comput Sci. 2024 Nov 18;10:e2445. doi: 10.7717/peerj-cs.2445. eCollection 2024. PeerJ Comput Sci. 2024. PMID: 39650463 Free PMC article.

8

Clinical Characteristics and Care Trajectories of Transgender and Gender Diverse Patients With Cancer Seen in a Pediatric Gender Clinic.

Bono MH, Smith HL, Williams CR, McGregor K, Berman AK, Boskey ER. Bono MH, et al. Among authors: smith hl. Psychooncology. 2024 Nov;33(11):e70017. doi: 10.1002/pon.70017. Psychooncology. 2024. PMID: 39505728

9

Treatment of equine keratomycosis, part 1: selection of appropriate therapy based on clinical presentation and diagnostic testing improves clinical outcomes.

Smith HL, Love KR, Antezana A, Barr EM, Gilger BC, Oh A. Smith HL, et al. J Am Vet Med Assoc. 2024 Oct 23;262(S2):S74-S84. doi: 10.2460/javma.24.06.0431. Print 2024 Dec 1. J Am Vet Med Assoc. 2024. PMID: 39442544

10

Structure and functional studies of Avt1, a novel peptide from the sea anemone Aulactinia veratra.

Albar RA, Smith HL, Sanches K, Wai DCC, Naseem MU, Szanto TG, Panyi G, Prentis PJ, Norton RS. Albar RA, et al. Among authors: smith hl. Biochim Biophys Acta Proteins Proteom. 2025 Jan 1;1873(1):141050. doi: 10.1016/j.bbapap.2024.141050. Epub 2024 Sep 30. Biochim Biophys Acta Proteins Proteom. 2025. PMID: 39357665 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters